2607.HK Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 apr 2024 @ 10:08):

Stats
Dagens volum	2.69M
Gjennomsnittsvolum	2.35M
Markedsverdi	57.04B
EPS	HKD0.320 ( 2023-10-27 )
Last Dividend	HKD0.664 ( 2023-07-18 )
Next Dividend	HKD0 ( N/A )
P/E	10.29
ATR14	HKD0.0170 (0.15%)

Volum Korrelasjon

Lang: -0.10 (neutral)

Kort: 0.28 (neutral)

Signal:(59.584) Neutral

Shanghai Pharmaceuticals Korrelasjon

10 Mest positive korrelasjoner

10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Shanghai Pharmaceuticals Korrelasjon - Valuta/Råvare

-0.06
( neutral )

-0.03
( neutral )

0.00
( neutral )

0.10
( neutral )

Shanghai Pharmaceuticals Økonomi

Annual	2023
Omsetning:	HKD260.30B
Bruttogevinst:	HKD31.33B (12.04 %)
EPS:	HKD1.020

FY	2023
Omsetning:	HKD260.30B
Bruttogevinst:	HKD31.33B (12.04 %)
EPS:	HKD1.020

FY	2022
Omsetning:	HKD231.98B
Bruttogevinst:	HKD30.49B (13.14 %)
EPS:	HKD1.610

FY	2021
Omsetning:	HKD215.82B
Bruttogevinst:	HKD28.54B (13.23 %)
EPS:	HKD1.790

Financial Reports:

No articles found.

Shanghai Pharmaceuticals Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
HKD0.984 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0.664 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)

Shanghai Pharmaceuticals Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 4.21 - Stable (15.80%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	HKD0.196	2012-06-14
Last Dividend	HKD0.664	2023-07-18
Next Dividend	HKD0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	13	--
Total Paid Out	HKD5.57	--
Avg. Dividend % Per Year	0.00%	--
Score	2.92	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	4.21
Div. Directional Score	7.63	--

Next Divdend (Est)
(2024-07-11)

HKD0.720 Estimate 3.11 %

Dividend Stability

0.25 Very Poor

Dividend Score

2.92

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for HKSE

Symbol	Title	Last dividend	Frequency	Yearly Dividend
8371.HK	Ex Dividend Junior	2023-08-03	Annually	0.00%
2020.HK	Ex Dividend Knight	2023-09-04	Semi-Annually	0.00%
1099.HK	Ex Dividend Junior	2023-06-19	Annually	0.00%
0168.HK	Ex Dividend Knight	2023-06-21	Annually	0.00%
3737.HK	Ex Dividend Junior	2023-10-17	Annually	0.00%
1668.HK	No Dividend Player	2023-09-26	Annually	0.00%
0710.HK	Ex Dividend Knight	2023-07-05	Annually	0.00%
2230.HK	Ex Dividend Knight	2023-09-21	Semi-Annually	0.00%
1243.HK	Ex Dividend Junior	2023-08-25	Annually	0.00%
0308.HK	Ex Dividend Junior	2023-09-18	Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0145	1.500	9.71	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0178	1.200	9.41	10.00	[0 - 0.3]
returnOnEquityTTM	0.0552	1.500	-0.498	-0.746	[0.1 - 1]
payoutRatioTTM	1.057	-1.000	10.00	-10.00	[0 - 1]
currentRatioTTM	1.327	0.800	8.36	6.69	[1 - 3]
quickRatioTTM	1.017	0.800	8.73	6.98	[0.8 - 2.5]
cashRatioTTM	0.249	1.500	9.73	10.00	[0.2 - 2]
debtRatioTTM	0.216	-1.500	6.39	-9.59	[0 - 0.6]
interestCoverageTTM	4.07	1.000	9.60	9.60	[3 - 30]
operatingCashFlowPerShareTTM	2.50	2.00	9.17	10.00	[0 - 30]
freeCashFlowPerShareTTM	1.709	2.00	9.15	10.00	[0 - 20]
debtEquityRatioTTM	0.669	-1.500	7.32	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.120	1.000	-1.327	-1.327	[0.2 - 0.8]
operatingProfitMarginTTM	0.0295	1.000	-1.411	-1.411	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.204	1.000	9.98	9.98	[0.2 - 2]
assetTurnoverTTM	1.228	0.800	5.15	4.12	[0.5 - 2]
Total Score				11.05

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	10.41	1.000	9.05	0	[1 - 100]
returnOnEquityTTM	0.0552	2.50	-0.320	-0.746	[0.1 - 1.5]
freeCashFlowPerShareTTM	1.709	2.00	9.43	10.00	[0 - 30]
dividendYielPercentageTTM	6.34	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	2.50	2.00	9.17	10.00	[0 - 30]
payoutRatioTTM	1.057	1.500	10.00	-10.00	[0 - 1]
pegRatioTTM	0.0450	1.500	-3.03	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0360	1.000	-1.600	0	[0.1 - 0.5]
Total Score				4.21

Shanghai Pharmaceuticals

Shanghai Pharmaceuticals Holding Co., Ltd., an investment holding company, researches, develops, manufactures, distributes, and retails pharmaceutical and healthcare products in the People's Republic of China. It operates through four segments: Production, Distribution, Retail, and Others. The company offers chemicals and biochemicals, Chinese medicines, healthcare products, and medical devices in various therapeutic areas, including oncology, cerebrocardiovascular, CNS, general infection, immunology, digestive and metabolism, and respiratory. It provides approximately 700 varieties of drugs. The company also engages in the provision of pharmaceutical distribution, warehousing, logistics, and other value-added pharmaceutical supply chain solutions and related services to pharmaceutical manufacturers and dispensers, such as hospitals, distributors, and retail pharmacies. In addition, it engages in the operation of a network of retail pharmacy stores; online drug business; and provision of consulting services, assets management operations, as well as clinical trials, medical aid, physicians and patients' education, e-prescription management, and remote and cloud hospitals. Further, the company manufactures and trades in medicines. It operates approximately 2,000 retail chain pharmacies in 24 provinces. The company was incorporated in 1994 and is headquartered in Shanghai, the People's Republic of China. Shanghai Pharmaceuticals Holding Co., Ltd. is a subsidiary of Shanghai Pharmaceutical (Group) Co., Ltd.